Clara Rodríguez-Bernal
Biographic Data
| ID | 5541114 |
|---|---|
| NAME | Clara Rodríguez-Bernal |
| GIVEN NAMES | Clara |
| FAMILY NAME | Rodríguez-Bernal |
| SIGNATURE | RODRÍGUEZ-BERNAL C |
| VERIFIED | No |
| TOTAL WORKS | 2 |
| TOTAL CITATIONS | 0 |
| WORKS AS AUTHOR | 2 |
| WORKS AS EDITOR | 0 |
| FIRST PUBLICATION YEAR | 2020 |
| LATEST PUBLICATION YEAR | 2025 |
| H-INDEX | 0 |
Association of glucagon-like peptide-1 receptor agonists with acute pancreatitis and biliary disease in individuals with diabetes and obesity
To evaluate the risk of acute pancreatitis and biliary disease in patients treated with glucagon-like peptide-1 receptor agonists (GLP-1 RA). Population-based, propensity-weighted, new user, active comparator design study including patients with diabetes and obesity initiating treatment with GLP-1 RA or the comparator group sodium-glucose cotransporter 2 inhibitors (SGLT-2i) in the region of Valencia from 2015 to 2021. In adjusted, per protocol m…
Group-based Trajectory Models to Assess Quality of INR Control and Its Association With Clinical Outcomes
BACKGROUND: The Time in Therapeutic Range (TTR) is the gold-standard measure used to assess the quality of oral anticoagulation with vitamin K antagonists. However, TTR is a static measure, and International Normalized Ratio (INR) control is a dynamic process. Group-based Trajectory Models (GBTM) can address this dynamic nature by classifying patients into different trajectories of INR control over time. OBJECTIVES: The objective of this study wa…
No prominent works on this page.
Group-based Trajectory Models to Assess Quality of INR Control and Its Association With Clinical Outcomes
BACKGROUND: The Time in Therapeutic Range (TTR) is the gold-standard measure used to assess the quality of oral anticoagulation with vitamin K antagonists. However, TTR is a static measure, and International Normalized Ratio (INR) control is a dynamic process. Group-based Trajectory Models (GBTM) can address this dynamic nature by classifying patients into different trajectories of INR control over time. OBJECTIVES: The objective of this study wa…
Association of glucagon-like peptide-1 receptor agonists with acute pancreatitis and biliary disease in individuals with diabetes and obesity
To evaluate the risk of acute pancreatitis and biliary disease in patients treated with glucagon-like peptide-1 receptor agonists (GLP-1 RA). Population-based, propensity-weighted, new user, active comparator design study including patients with diabetes and obesity initiating treatment with GLP-1 RA or the comparator group sodium-glucose cotransporter 2 inhibitors (SGLT-2i) in the region of Valencia from 2015 to 2021. In adjusted, per protocol m…
Medicine (2 works) · Acute pancreatitis (1 work) · Agonist (1 work) · Artificial Intelligence (1 work) · Artificial Intelligence (1 work) · Association (psychology) (1 work) · Atrial Fibrillation Management and Outcomes (1 work) · Bariatric Surgery and Outcomes (1 work) · Cohort (1 work) · Cohort study (1 work)